We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Benign Hematology

Journal Scan / Research · January 19, 2021

Autologous HSCT and the Development of Second Primary Malignancies in Multiple Myeloma Patients

Blood Cancer Journal

 

Additional Info

Blood Cancer Journal
Effect of Autologous Hematopoietic Stem Cell Transplant on the Development of Second Primary Malignancies in Multiple Myeloma Patients
Blood Cancer J 2021 Jan 07;11(1)5, AS Rosenberg, A Brunson, J Tuscano, BA Jonas, R Hoeg, T Wun, THM Keegan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading